(S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
SKU | RCLST509539 |
---|---|
CAS number | 289472-81-7 |
Molecular Formula | C19H24N4O3 |
Catalog Number | RCLST509539 |
Chemical Name | (S)-Hydroxy Des(boric Acid) Bortezomib |
Synonyms | N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide; N-[(1S)-2-[[(1S)-1-hydroxy-3-8methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-pyrazinecarboxamide; Bortezomib USP Impurity J |
Molecular Weight | 356.42 |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Stability | No Data Available |
Appearance | White to Off-White Solid |
Storage Condition | -20°C Freezer |